Short answer
STANDARD BIOTOOLS INC. (LAB) filed an 8-K current report with the SEC on April 24, 2026 reporting Item 3.01 (Notice of Delisting). Nasdaq deficiency triggered by LAB closing below $1.00 for 30 consecutive business days.
- This filing includes Item 3.01, an item that often signal trouble.
STANDARD BIOTOOLS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Nasdaq deficiency triggered by LAB closing below $1.00 for 30 consecutive business days
- No immediate delisting; LAB continues trading uninterrupted on Nasdaq Global Select Market
- Compliance deadline October 19, 2026, requiring $1.00 minimum bid for 10 consecutive business days
- Potential additional 180-day period requires Nasdaq Capital Market transfer and satisfaction of other listing standards
- Reverse stock split identified as a possible compliance measure, creating shareholder dilution and volatility risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other STANDARD BIOTOOLS INC. 8-K filings
Get the next LAB 8-K as it lands
Follow LAB for push alerts, or ask the research agent what this filing means.